Infections caused by Acinetobacter baumannii in cancer patients
Автор: Dmitrieva Natalia V., Eidelshtein Mikhail V., Aginova Viktoria V., Grigorievskaya Zlata V., Petukhova Irina N., Tereshchenko Inna V., Bagirova Natalia S., Dyakova Svetlana A., Kalinchuk Tatiana A., Dmitrieva Anna I., Shek Evgeny A., Skleenova Elena Yu.
Журнал: Сибирский онкологический журнал @siboncoj
Рубрика: Клинические исследования
Статья в выпуске: 3 т.18, 2019 года.
Бесплатный доступ
The purpose of the study was to evaluate the frequency of isolation of multi-resistant Acinetobacter baumannii in cancer patients and identify the mechanisms of resistance to carbapenems. Material and Methods. We analyzed 942 strains of A. baumannii isolated from clinical samples of cancer patients in the period 2014-16. The level of resistance to ampicillin-sulbactam, piperacillin-tazobactam, ceftazidime, cefepime, imipenem, meropenem, ciprofloxacin, amikacin, and to other antibiotics was determined. Carbapenem-resistant (Car-R) strains were examined for the presence of carbapenemases. Results. Between 2014 and 2016, the number of strains resistant to: ampicillin-sulbactam was 95.5-74.6 % (p
Оxа-23, сar-r, acinetobacter baumannii, cancer patients, carbapenemases, multi-drug resistant organisms, carbapenems, antibiotics
Короткий адрес: https://sciup.org/140254259
IDR: 140254259 | DOI: 10.21294/1814-4861-2019-18-3-26-33
